Patient and provider acceptance of telecoaching in type 2 diabetes: a mixed-method study embedded in a randomised clinical trial

被引:15
|
作者
Odnoletkova, I. [1 ]
Buysse, H. [2 ]
Nobels, F. [3 ]
Goderis, G. [4 ]
Aertgeerts, B. [4 ]
Annemans, L. [2 ]
Ramaekers, D. [1 ]
机构
[1] Katholieke Univ Leuven, Leuven Inst Healthcare Policy, Kapucijnenvoer 33, B-3000 Leuven, Belgium
[2] Univ Ghent, Dept Publ Hlth, De Pintelaan 185, B-9000 Ghent, Belgium
[3] OLV Hosp Aalst, Dept Endocrinol, Moorselbaan 164, B-9300 Aalst, Belgium
[4] Katholieke Univ Leuven, Acad Ctr Gen Practice, Kapucijnenvoer 33, B-3000 Leuven, Belgium
关键词
Patient education; Telecare; Type; 2; diabetes; Qualitative research; SELF-MANAGEMENT EDUCATION; QUALITATIVE RESEARCH; HEALTH; TELECARE; IMPLEMENTATION; BARRIERS; PROGRAM; CARE;
D O I
10.1186/s12911-016-0383-3
中图分类号
R-058 [];
学科分类号
摘要
Background: Despite advances in diagnosis and treatment of type 2 diabetes, suboptimal metabolic control persists. Patient education in diabetes has been proved to enhance self-efficacy and guideline-driven treatment, however many people with type 2 diabetes do not have access to or do not participate in self-management support programmes. Tele-education and telecoaching have the potential to improve accessibility and efficiency of care, but there is a slow uptake in Europe. Patient and provider acceptance in a local context is an important precondition for implementation. The aim of the study was to explore the perceptions of patients, nurses and general practitioners (GPs) regarding telecoaching in type 2 diabetes. Methods: Mixed-method study embedded in a clinical trial, in which a nurse-led target-driven telecoaching programme consisting of 5 monthly telephone sessions of +/- 30 min was offered to 287 people with type 2 diabetes in Belgian primary care. Intervention attendance and satisfaction about the programme were analysed along with qualitative data obtained during post-trial semi-structured interviews with a purposive sample of patients, general practitioners (GPs) and nurses. The perceptions of patients and care providers about the intervention were coded and the themes interpreted as barriers or facilitators for adoption. Results: Of 252 patients available for a follow-up analysis, 97.5 % reported being satisfied. Interviews were held with 16 patients, 17 general practitioners (GPs) and all nurses involved (n = 6). Themes associated with adoption facilitation were: 1) improved diabetes control; 2) need for more tailored patient education programmes offered from the moment of diagnosis; 3) comfort and flexibility; 4) evidence-based nature of the programme; 5) established cooperation between GPs and diabetes educators; and 6) efficiency gains. Most potential barriers were derived from the provider views: 1) poor patient motivation and suboptimal compliance with "faceless" advice; 2) GPs' reluctance in the area of patient referral and information sharing; 3) lack of legal, organisational and financial framework for telecare. Conclusions: Nurse-led telecoaching of people with type 2 diabetes was well-accepted by patients and providers, with providers being in general more critical in their reflections. With increasing patient demand for mobile and remote services in healthcare,the findings of this study should support professionals involved in healthcare policy and innovation.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [41] Use of patient-reported outcome measures (PROMs) in clinical diabetes consultations: study protocol for the DiaPROM randomised controlled trial pilot study
    Haugstvedt, Anne
    Hernar, Ingvild
    Strandberg, Ragnhild Bjarkoy
    Richards, David A.
    Nilsen, Roy Miodini
    Tell, Grethe S.
    Graue, Marit
    BMJ OPEN, 2019, 9 (01):
  • [42] Occurrence of Type 1 Diabetes in a Patient Enrolled in an Immunotherapy Combination Phase 1 Clinical Trial: A Case Study
    Charles, Sheena
    Poullard, Anna
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2021, 8 (06) : 737 - 739
  • [43] The (cost) effectiveness of a very low-energy diet intervention with the use of eHealth in patients with type 2 diabetes and obesity: study protocol for a randomised controlled non-inferiority trial (E-diet trial)
    Geurts, Karlijn A. M.
    Ozcan, Behiye
    van Hoek, Mandy
    van de Laar, Roel
    van Teeffelen, Jolande
    van Rosmalen, Joost
    van Rossum, Elisabeth F. C.
    Berk, Kirsten A.
    TRIALS, 2023, 24 (01)
  • [44] Patient-Provider Social Concordance and Health Outcomes in Patients with Type 2 Diabetes: a Retrospective Study from a Large Federally Qualified Health Center in Connecticut
    Kurek, Kimberley
    Teevan, Bridget E.
    Zlateva, Ianita
    Anderson, Daren R.
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2016, 3 (02) : 217 - 224
  • [45] Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial Programme
    Boye, Kristina S. S.
    Thieu, Vivian Thuyanh
    Sapin, Helene
    Lee, Clare J. J.
    Lando, Laura Fernandez
    Brown, Katelyn
    Bray, Ross
    Wiese, Russell J. J.
    Patel, Hiren
    Rodriguez, Angel
    Yu, Maria
    DIABETES THERAPY, 2023, 14 (11) : 1833 - 1852
  • [46] Evaluation of parent and youth experiences in advisory groups as part of a mental healthcare clinical trial: protocol for a mixed-method study
    Rasiah, Jananee
    Freedman, Stephen
    Macdonald, Lee
    Prisnie, Kassi
    Eltorki, Mohamed
    Finkelstein, Yaron
    Hopkin, Gareth
    Santana, Maria-Jose
    Thull-Freedman, Jennifer
    Stang, Antonia
    Prebeg, Matthew
    Gagnon, Isabelle J.
    Steele, Margaret
    Mater, Ahmed
    Katz, Laurence
    Greenfield, Brian
    Plotnick, Laurie
    Monga, Suneeta
    Lipman, Ellen Louise
    Wright, Bruce
    Dimitropoulos, Gina
    Porter, Robert
    Hurley, Katrina
    Al Hamarneh, Yazid N.
    Newton, Amanda
    BMJ OPEN, 2022, 12 (06):
  • [47] The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial
    Welschen, Laura M. C.
    Bot, Sandra D. M.
    Dekker, Jacqueline M.
    Timmermans, Danielle R. M.
    van der Weijden, Trudy
    Nijpels, Giel
    BMC PUBLIC HEALTH, 2010, 10
  • [48] Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
    Lingvay, Ildiko
    Benamar, Malik
    Chen, Liming
    Fu, Ariel
    Jodar, Esteban
    Nishida, Tomoyuki
    Riveline, Jean-Pierre
    Yabe, Daisuke
    Zueger, Thomas
    Rea, Rosangela
    DIABETOLOGIA, 2025, : 739 - 751
  • [49] Socio-demographic, behavioural and clinical factors influencing control of diabetes and hypertension in urban Mysore, South India: a mixed-method study conducted in 2018
    Dey, Sudeshna
    Mukherjee, Aparna
    Pati, Manoj Kumar
    Kar, Arin
    Ramanaik, Satyanarayana
    Pujar, Ashwini
    Malve, Vidyacharan
    Mohan, H. L.
    Jayanna, Krishnamurthy
    Swaroop, N.
    ARCHIVES OF PUBLIC HEALTH, 2022, 80 (01)
  • [50] Effect of a multifactorial intervention on the increase in physical activity in subjects with type 2 diabetes mellitus: a randomized clinical trial (EMID Study)
    Alonso-Dominguez, Rosario
    Patino-Alonso, Maria C.
    Sanchez-Aguadero, Natalia
    Garcia-Ortiz, Luis
    Recio-Rodriguez, Jose I.
    Gomez-Marcos, Manuel A.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2019, 18 (05) : 399 - 409